Developmental control of replication initiation and genome stability
- Institution
- VANDERBILT UNIVERSITY, TN
- Principal investigator
- Jared Nordman
- Funding
- $428K
- Duration
- 2018–2028
Moonbase score
Still being scored
Abstract
Project Summary Every cell division requires the faithful duplication of genetic material from mother cell to daughter cell. Defects in the proper execution of the DNA replication program can directly result in the genome instability that is a hallmark of nearly all cancer cells. To ensure genome stability, the machinery responsible for DNA replication must be highly regulated. There must be enough flexibility built into the DNA replication program, however, to accommodate the dramatic changes in cell cycle and S phase progression that occur during the development of an organism. Understanding this regulation is imperative to determine how genome stability is maintained during development. We utilize the powerful developmental systems available in Drosophila to identify key regulators of the DNA replication program, with the ultimate goal of delineating the molecular underpinnings responsible for regulating genome duplication and stability during development. Our main focus is understanding how replication initiation is regulated to ensure genome stability. We have defined three key projects where the strength of our system positions us to make key insights. These include: 1) understanding the functional relationship between nuclear pore proteins and the Origin Recognition Complex (ORC). 2) Defining the key targets and molecular mechanisms Rif1 uses to influence replication initiation. 3) Identifying and characterizing posttranslational modifications of ORC that affect replication initiation.
LOADING MOONBASE SCORE
Questions for VANDERBILT UNIVERSITY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Vanderbilt University64
The role of tumor expression of alpha-myosin in immune checkpoint inhibitor-associated myocarditis
Reilly Garrett Fankhauser · $35K · 2026–2029
- NIH · Vanderbilt University62
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias
Ethan Lippmann · $766K · 2022–2027
- NIH · Vanderbilt University51
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer
Krishna Chaitanya Mudumbi · $249K · 2025–2027